Related Experiment Video
Updated: Jun 16, 2025
08:29
Ex Vivo Treatment Response of Primary Tumors and/or Associated Metastases for Preclinical and Clinical Development of Therapeutics
Published on: October 2, 2014
14.7K
HSP90 multi-functionality in cancer
1Department of Biology, Lomonosov Moscow State University, Moscow, Russia.
Frontiers in Immunology
|August 16, 2024
Summary
Heat shock proteins (HSP90s) are crucial molecular chaperones that support cancer progression by aiding tumor survival and growth. Understanding HSP90s offers potential for new cancer treatment strategies.
Area of Science:
- Molecular Biology
- Oncology
- Biochemistry
Background:
- Heat shock proteins (HSP90s) are essential molecular chaperones involved in protein folding, unfolding, and degradation.
- HSP90s and their co-chaperones undergo post-translational modifications, with unclear functional impacts in cancer.
- HSP90 family members promote cancer progression by supporting key hallmarks like resistance to cell death and metastasis.
Purpose of the Study:
- To review the multifaceted roles of HSP90 proteins in cancer development and progression.
- To highlight the therapeutic potential of targeting HSP90s in oncology.
- To explore novel therapeutic strategies based on HSP90 functions in cancer.
Main Methods:
- Literature review of HSP90 functions in cancer.
- Analysis of HSP90 family members (HSP90α, HSP90β, GRP94, TRAP1) in cancer hallmarks.
- Examination of existing HSP90 inhibitors and vaccines for cancer treatment.
Main Results:
- HSP90s are vital for multiple cancer hallmarks, including survival, immortality, immune evasion, and metastasis.
- Post-translational modifications of HSP90s in cancer require further investigation.
- Targeting HSP90s has led to the development of therapeutic agents for cancer treatment.
Conclusions:
- HSP90 proteins play a critical role in sustaining cancer progression.
- Further research into HSP90 functions can unveil new therapeutic avenues for cancer.
- Targeting HSP90s represents a promising strategy for developing novel cancer therapies.
Related Concept Videos
03:03mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
01:19Interactions Between Signaling Pathways
6.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K
02:23Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
01:22PI3K/mTOR/AKT Signaling Pathway
3.5K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.5K
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
01:31The Intrinsic Apoptotic Pathway
6.4K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.4K